Ligand validation:3SLT

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 3SLT designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3SLT_C8E_A_1306	19%	79%	0.152	0.843	0.25	0.61	-	-	0	0	48%	0.4762
3SLT_C8E_A_1	8%	79%	0.254	0.723	0.45	0.42	-	-	2	0	100%	1
3SLT_C8E_A_1308	6%	80%	0.286	0.726	0.43	0.42	-	-	0	0	100%	1
3SLT_C8E_A_1301	6%	75%	0.287	0.79	0.42	0.57	-	-	0	0	62%	0.619
3SLT_C8E_A_1303	6%	85%	0.269	0.764	0.41	0.34	-	-	0	0	62%	0.619
3SLT_C8E_A_1305	6%	83%	0.355	0.839	0.43	0.36	-	-	0	0	67%	0.6667
3SLT_C8E_A_1304	4%	89%	0.256	0.747	0.39	0.25	-	-	0	0	29%	0.2857
3SLT_C8E_A_1302	3%	75%	0.293	0.658	0.44	0.55	-	-	1	0	81%	0.8095
3SLT_C8E_A_1307	3%	85%	0.431	0.871	0.34	0.39	-	-	0	0	38%	0.381
3SLT_C8E_A_1309	3%	89%	0.265	0.688	0.44	0.22	-	-	0	0	43%	0.4286
3SLJ_C8E_A_1	14%	80%	0.199	0.83	0.31	0.53	-	-	0	0	57%	0.5714
3SLO_C8E_A_1304	10%	66%	0.267	0.807	0.56	0.75	-	-	1	0	81%	0.8095
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	2	0	100%	1
3RGN_C8E_A_800	76%	74%	0.112	0.947	0.34	0.66	-	-	0	0	100%	1
6EHD_C8E_A_409	64%	60%	0.105	0.903	0.42	1.08	-	2	3	0	100%	1
5MDO_C8E_B_404	62%	74%	0.118	0.908	0.36	0.65	-	-	0	0	100%	1
5DL7_C8E_A_506	61%	46%	0.123	0.912	0.72	1.34	-	3	4	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.